The University of Chicago Header Logo

Connection

Godfrey Getz to Mice

This is a "connection" page, showing publications Godfrey Getz has written about Mice.
Connection Strength

1.505
  1. Diet and murine atherosclerosis. Arterioscler Thromb Vasc Biol. 2006 Feb; 26(2):242-9.
    View in: PubMed
    Score: 0.098
  2. Insights from Murine Studies on the Site Specificity of Atherosclerosis. Int J Mol Sci. 2024 Jun 09; 25(12).
    View in: PubMed
    Score: 0.088
  3. Pig and Mouse Models of Hyperlipidemia and Atherosclerosis. Methods Mol Biol. 2022; 2419:379-411.
    View in: PubMed
    Score: 0.074
  4. Invariant Natural Killer T-Cells and Total CD1d Restricted Cells Differentially Influence Lipid Metabolism and Atherosclerosis in Low Density Receptor Deficient Mice. Int J Mol Sci. 2019 Sep 14; 20(18).
    View in: PubMed
    Score: 0.063
  5. Diet, Microbes, and Murine Atherosclerosis. Arterioscler Thromb Vasc Biol. 2018 10; 38(10):2269-2271.
    View in: PubMed
    Score: 0.059
  6. Genetic control of apoprotein A-I and atheroprotection: some insights from inbred strains of mice. Curr Opin Lipidol. 2017 Oct; 28(5):403-407.
    View in: PubMed
    Score: 0.055
  7. ApoE knockout and knockin mice: the history of their contribution to the understanding of atherogenesis. J Lipid Res. 2016 05; 57(5):758-66.
    View in: PubMed
    Score: 0.050
  8. Naturally occurring variant of mouse apolipoprotein A-I alters the lipid and HDL association properties of the protein. J Lipid Res. 2012 May; 53(5):951-963.
    View in: PubMed
    Score: 0.038
  9. 4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice. FASEB J. 2011 Jan; 25(1):290-300.
    View in: PubMed
    Score: 0.034
  10. High-density lipoprotein function in regulating insulin secretion: possible relevance to metabolic syndrome. Arterioscler Thromb Vasc Biol. 2010 Aug; 30(8):1497-9.
    View in: PubMed
    Score: 0.034
  11. An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide. J Lipid Res. 2009 Sep; 50(9):1889-900.
    View in: PubMed
    Score: 0.031
  12. VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice. J Lipid Res. 2009 Mar; 50(3):376-385.
    View in: PubMed
    Score: 0.030
  13. The two Cs: ceramide and cardiomyopathy. J Lipid Res. 2008 Oct; 49(10):2077-8.
    View in: PubMed
    Score: 0.029
  14. The specific amino acid sequence between helices 7 and 8 influences the binding specificity of human apolipoprotein A-I for high density lipoprotein (HDL) subclasses: a potential for HDL preferential generation. J Biol Chem. 2008 Jun 06; 283(23):15779-88.
    View in: PubMed
    Score: 0.029
  15. Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties. J Lipid Res. 2008 Jun; 49(6):1268-83.
    View in: PubMed
    Score: 0.029
  16. Murine atherosclerosis. Part III. Curr Drug Targets. 2008 Mar; 9(3):173.
    View in: PubMed
    Score: 0.029
  17. SAA, HDL biogenesis, and inflammation. J Lipid Res. 2008 Feb; 49(2):269-70.
    View in: PubMed
    Score: 0.028
  18. The immune system and murine atherosclerosis. Curr Drug Targets. 2007 Dec; 8(12):1297-306.
    View in: PubMed
    Score: 0.028
  19. Overview of murine atherosclerosis series. Curr Drug Targets. 2007 Nov; 8(11):1144-9.
    View in: PubMed
    Score: 0.028
  20. Characterization of the natural killer T-cell response in an adoptive transfer model of atherosclerosis. Am J Pathol. 2007 Mar; 170(3):1100-7.
    View in: PubMed
    Score: 0.027
  21. Site-specific influence of polyunsaturated fatty acids on atherosclerosis in immune incompetent LDL receptor deficient mice. Atherosclerosis. 2006 Aug; 187(2):325-31.
    View in: PubMed
    Score: 0.024
  22. Paraoxonase, a cardioprotective enzyme: continuing issues. Curr Opin Lipidol. 2004 Jun; 15(3):261-7.
    View in: PubMed
    Score: 0.022
  23. Autoantibodies to OxLDL fail to alter the clearance of injected OxLDL in apolipoprotein E-deficient mice. J Lipid Res. 2004 Jul; 45(7):1347-54.
    View in: PubMed
    Score: 0.022
  24. Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler Thromb Vasc Biol. 2004 Jan; 24(1):12-22.
    View in: PubMed
    Score: 0.021
  25. Influence of apoA-I and apoE on the formation of serum amyloid A-containing lipoproteins in vivo and in vitro. J Lipid Res. 2004 Feb; 45(2):317-25.
    View in: PubMed
    Score: 0.021
  26. Lipoproteins produced by ApoE-/- astrocytes infected with adenovirus expressing human ApoE. J Neurochem. 2003 Sep; 86(6):1391-402.
    View in: PubMed
    Score: 0.021
  27. Genetic background selectively influences innominate artery atherosclerosis: immune system deficiency as a probe. Arterioscler Thromb Vasc Biol. 2003 Aug 01; 23(8):1449-54.
    View in: PubMed
    Score: 0.021
  28. Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response. J Lipid Res. 2003 Apr; 44(4):780-92.
    View in: PubMed
    Score: 0.020
  29. Import of yeast mitochondrial transcription factor (Mtf1p) via a nonconventional pathway. J Biol Chem. 2002 Nov 22; 277(47):45704-14.
    View in: PubMed
    Score: 0.020
  30. Do natural killer cells participate in a killer vascular disease? Arterioscler Thromb Vasc Biol. 2002 Aug 01; 22(8):1251-3.
    View in: PubMed
    Score: 0.019
  31. Apolipoprotein A-I alpha -helices 7 and 8 modulate high density lipoprotein subclass distribution. J Biol Chem. 2002 Mar 22; 277(12):9645-54.
    View in: PubMed
    Score: 0.019
  32. Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2001 Jun; 21(6):1011-6.
    View in: PubMed
    Score: 0.018
  33. Mouse models of atherosclerosis. Curr Opin Lipidol. 2001 Apr; 12(2):167-73.
    View in: PubMed
    Score: 0.018
  34. Mouse model of unstable atherosclerotic plaque? Arterioscler Thromb Vasc Biol. 2000 Dec; 20(12):2503-5.
    View in: PubMed
    Score: 0.017
  35. SAA-only HDL formed during the acute phase response in apoA-I+/+ and apoA-I-/- mice. J Lipid Res. 1999 Jun; 40(6):1090-103.
    View in: PubMed
    Score: 0.016
  36. Deficiency of Invariant Natural Killer T Cells Does Not Protect Against Obesity but Exacerbates Atherosclerosis in Ldlr-/- Mice. Int J Mol Sci. 2018 Feb 08; 19(2).
    View in: PubMed
    Score: 0.014
  37. HDL content and composition in acute phase response in three species: triglyceride enrichment of HDL a factor in its decrease. J Lipid Res. 1996 Dec; 37(12):2662-74.
    View in: PubMed
    Score: 0.013
  38. Serum amyloid A regulates monopoiesis in hyperlipidemic Ldlr(-/-) mice. FEBS Lett. 2016 08; 590(16):2650-60.
    View in: PubMed
    Score: 0.013
  39. The western-type diet induces anti-HMGB1 autoimmunity in Apoe(-/-) mice. Atherosclerosis. 2016 08; 251:31-38.
    View in: PubMed
    Score: 0.013
  40. Enzymatically Modified Low-Density Lipoprotein Promotes Foam Cell Formation in Smooth Muscle Cells via Macropinocytosis and Enhances Receptor-Mediated Uptake of Oxidized Low-Density Lipoprotein. Arterioscler Thromb Vasc Biol. 2016 06; 36(6):1101-13.
    View in: PubMed
    Score: 0.013
  41. Lipoprotein association of human apolipoprotein E/A-I chimeras. Expression in transfected hepatoma cells. J Biol Chem. 1996 Mar 15; 271(11):6062-70.
    View in: PubMed
    Score: 0.012
  42. Proteomic analysis of HDL from inbred mouse strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway. J Lipid Res. 2016 Feb; 57(2):246-57.
    View in: PubMed
    Score: 0.012
  43. Alginic acid cell entrapment: a novel method for measuring in vivo macrophage cholesterol homeostasis. J Lipid Res. 2015 Feb; 56(2):470-83.
    View in: PubMed
    Score: 0.011
  44. Selective suppression of adipose tissue apoE expression impacts systemic metabolic phenotype and adipose tissue inflammation. J Lipid Res. 2015 Feb; 56(2):215-26.
    View in: PubMed
    Score: 0.011
  45. The apolipoprotein-AI mimetic peptide L4F at a modest dose does not attenuate weight gain, inflammation, or atherosclerosis in LDLR-null mice. PLoS One. 2014; 9(10):e109252.
    View in: PubMed
    Score: 0.011
  46. Cutting edge: Dexamethasone potentiates the responses of both regulatory T cells and B-1 cells to antigen immunization in the ApoE(-/-) mouse model of atherosclerosis. J Immunol. 2014 Jul 01; 193(1):35-9.
    View in: PubMed
    Score: 0.011
  47. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background. Arterioscler Thromb Vasc Biol. 2014 Feb; 34(2):262-9.
    View in: PubMed
    Score: 0.011
  48. Increased levels of invariant natural killer T lymphocytes worsen metabolic abnormalities and atherosclerosis in obese mice. J Lipid Res. 2013 Oct; 54(10):2831-41.
    View in: PubMed
    Score: 0.010
  49. Differing rates of cholesterol absorption among inbred mouse strains yield differing levels of HDL-cholesterol. J Lipid Res. 2013 Sep; 54(9):2515-24.
    View in: PubMed
    Score: 0.010
  50. LIGHT/TNFSR14 can regulate hepatic lipase expression by hepatocytes independent of T cells and Kupffer cells. PLoS One. 2013; 8(1):e54719.
    View in: PubMed
    Score: 0.010
  51. Dexamethasone promotes tolerance in vivo by enriching CD11clo CD40lo tolerogenic macrophages. Eur J Immunol. 2013 Jan; 43(1):219-27.
    View in: PubMed
    Score: 0.010
  52. ApoE derived from adipose tissue does not suppress atherosclerosis or correct hyperlipidemia in apoE knockout mice. J Lipid Res. 2013 Jan; 54(1):202-13.
    View in: PubMed
    Score: 0.010
  53. Vitamin D receptor signaling inhibits atherosclerosis in mice. Mol Endocrinol. 2012 Jul; 26(7):1091-101.
    View in: PubMed
    Score: 0.010
  54. Human oxidation-specific antibodies reduce foam cell formation and atherosclerosis progression. J Am Coll Cardiol. 2011 Oct 11; 58(16):1715-27.
    View in: PubMed
    Score: 0.009
  55. A novel potent synthetic steroidal liver X receptor agonist lowers plasma cholesterol and triglycerides and reduces atherosclerosis in LDLR(-/-) mice. Br J Pharmacol. 2011 Apr; 162(8):1792-804.
    View in: PubMed
    Score: 0.009
  56. Environmentally induced differential amplification of mitochondrial populations. Biochem J. 1990 Sep 01; 270(2):511-8.
    View in: PubMed
    Score: 0.008
  57. Differential effects of activation of liver X receptor on plasma lipid homeostasis in wild-type and lipoprotein clearance-deficient mice. Atherosclerosis. 2010 Jan; 208(1):126-33.
    View in: PubMed
    Score: 0.008
  58. Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice. J Exp Med. 2009 Jan 16; 206(1):233-48.
    View in: PubMed
    Score: 0.008
  59. Antiatherosclerotic effects of a novel synthetic tissue-selective steroidal liver X receptor agonist in low-density lipoprotein receptor-deficient mice. J Pharmacol Exp Ther. 2008 Nov; 327(2):332-42.
    View in: PubMed
    Score: 0.007
  60. Differential anti-atherosclerotic effects in the innominate artery and aortic sinus by the liver X receptor agonist T0901317. Atherosclerosis. 2009 Mar; 203(1):59-66.
    View in: PubMed
    Score: 0.007
  61. Apoprotein E mediates the interaction of beta-VLDL with macrophages. J Lipid Res. 1987 Jul; 28(7):787-97.
    View in: PubMed
    Score: 0.007
  62. Lymphotoxin beta receptor-dependent control of lipid homeostasis. Science. 2007 Apr 13; 316(5822):285-8.
    View in: PubMed
    Score: 0.007
  63. Self-assembly of HEK cell-secreted ApoE particles resembles ApoE enrichment of lipoproteins as a ligand for the LDL receptor-related protein. Biochemistry. 2006 Jan 17; 45(2):381-90.
    View in: PubMed
    Score: 0.006
  64. Engineering mouse apolipoprotein A-I into a monomeric, active protein useful for structural determination. Biochemistry. 2005 Nov 15; 44(45):14907-19.
    View in: PubMed
    Score: 0.006
  65. Chemical colloids versus biological colloids: a comparative study for the elucidation of the mechanism of protein fiber formation. Biochemistry. 2005 Apr 12; 44(14):5381-9.
    View in: PubMed
    Score: 0.006
  66. Very low density lipoproteins promote triglyceride accumulation in macrophages. Arteriosclerosis. 1984 Mar-Apr; 4(2):103-14.
    View in: PubMed
    Score: 0.005
  67. Both apolipoprotein E and immune deficiency exacerbate neointimal hyperplasia after vascular injury in mice. Arterioscler Thromb Vasc Biol. 2002 Mar 01; 22(3):450-5.
    View in: PubMed
    Score: 0.005
  68. In vivo studies of HDL assembly and metabolism using adenovirus-mediated transfer of ApoA-I mutants in ApoA-I-deficient mice. Biochemistry. 2001 Nov 13; 40(45):13670-80.
    View in: PubMed
    Score: 0.005
  69. DNA microarrays identification of primary and secondary target genes regulated by p53. Oncogene. 2001 Apr 26; 20(18):2225-34.
    View in: PubMed
    Score: 0.004
  70. Loss of atheroprotective effect of estradiol in immunodeficient mice. Endocrinology. 2000 Jan; 141(1):462-5.
    View in: PubMed
    Score: 0.004
  71. Unique lipoproteins secreted by primary astrocytes from wild type, apoE (-/-), and human apoE transgenic mice. J Biol Chem. 1999 Oct 15; 274(42):30001-7.
    View in: PubMed
    Score: 0.004
  72. Cytoplasmically inherited respiratory deficiency of a mouse fibroblast line which is resistant to rutamycin. Biochemistry. 1979 Jun 12; 18(12):2582-90.
    View in: PubMed
    Score: 0.004
  73. The receptor-mediated accumulation of triglyceride in macrophage exposed to very low density lipoproteins. Acta Acad Med Wuhan. 1983; 3(1):8-15.
    View in: PubMed
    Score: 0.001
  74. Alteration of protein synthesis and induction of specific protein phosphorylation by hyperthermia. Cancer Res. 1982 Apr; 42(4):1395-8.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.